Research highlights from the International Journal of Nanomedicine 2014
نویسندگان
چکیده
منابع مشابه
Research highlights from the International Journal of Nanomedicine 2014
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be f...
متن کاملResearch highlights: Highlights from the last year in nanomedicine.
Synthetic biology attempts to reproduce emergent behaviors from natural biology with the goal of creating artificial life. The main challenge in this field is the reduction of complex phenomena into functional components, which can be individually engineered and later combined to replicate the macroscopic behavior of the model biological system. Nawroth and coworkers reverse-engineered the mech...
متن کاملEditor’s choice: recent research highlights from the International Journal of Nanomedicine
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, pleas...
متن کاملTourette Syndrome research highlights 2014
About 200 journal articles reported research on Tourette syndrome and other tic disorders in 2014. Here we briefly summarize a few of the reports that seemed most important or interesting, ranging from animal models to human studies. Readers can comment on our choices or provide their own favorites using the tools on the online article. This article is included in the channel. Tics 1
متن کاملHighlights from easl 2014.
Twelve-week sustained viral response (SVR) rates ranging from 94% to 99% have been reported in treatmentexperienced patients infected with genotype 1 hepatitis C virus (HCV) infection following 12 to 24 weeks of therapy with sofosbuvir (Sovaldi, Gilead) and ledipasvir (fixed-dose combination) with or without ribavirin. The study population included patients with cirrhosis and those who failed p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Nanomedicine
سال: 2015
ISSN: 1178-2013
DOI: 10.2147/ijn.s81085